NOVARTIS FARMACEUTICA supplier risk profile Q1-2026: Mexico pharma importer, B-grade compliance, 2 suppliers.
NOVARTIS FARMACEUTICA imported 95 shipments in Q1 2026 across 11 HS codes from just 2 suppliers, both pharmaceutical and chemical manufacturers. Switzerland dominated sourcing at 78.8% of shipments via NOVARTIS PHARMA, while Q SQUARED SOLUTIONS (US) supplied 21.1%. The importer's trade is heavily concentrated in HS chapter 30 (pharmaceuticals), with HS code 300490 alone accounting for 61.1% of all shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
The importer registered zero matches on sanctions watchlists and zero suppliers with direct UFLPA forced-labor exposure. Supply-chain depth extends to 25 tier-3 entities, indicating indirect sourcing complexity that warrants standard monitoring protocols.
2 distinct tier-1 suppliers in Q1 2026
| NOVARTIS PHARMA | Switzerland | 74 |
| Q SQUARED SOLUTIONS | United States | 21 |
Share of Q1 2026 inbound shipments by source country
10 tier-2 + 25 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.